BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7522951)

  • 61. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ultrasonic evaluation of trophoblastic disease and the response to chemotherapy.
    Murao F; Takamori H; Aoki S; Hata K; Hata T; Takahashi K; Kitao M
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1137-42. PubMed ID: 3039021
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High-dose methotrexate for gestational trophoblastic disease.
    Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
    Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
    [TBL] [Abstract][Full Text] [Related]  

  • 65. New criteria for the diagnosis of gestational trophoblastic disease.
    Romero R; Horgan JG; Kohorn EI; Kadar N; Taylor KJ; Hobbins JC
    Obstet Gynecol; 1985 Oct; 66(4):553-8. PubMed ID: 2995891
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular heterogeneity of hCGbeta--related glycoproteins and the clinical relevance in trophoblastic and non-trophoblastic tumors.
    Nishimura R; Koizumi T; Yokotani T; Taniguchi R; Morisue K; Yoshimura M; Hiranmoy D; Yamaguchi S; Nakagawa T; Hasegawa K; Yasui H
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S29-32. PubMed ID: 9833612
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical and laboratory investigation of a virilized woman with placental-site trophoblastic tumor.
    Nagelberg SB; Rosen SW
    Obstet Gynecol; 1985 Apr; 65(4):527-34. PubMed ID: 2984618
    [TBL] [Abstract][Full Text] [Related]  

  • 69. From the archives of the AFIP. Gestational trophoblastic disease: radiologic-pathologic correlation.
    Wagner BJ; Woodward PJ; Dickey GE
    Radiographics; 1996 Jan; 16(1):131-48. PubMed ID: 10946695
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Ultrasonographic study of trophoblastic neoplasms. A report of 185 cases].
    Fang YX; Kong QY
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):28-30, 61. PubMed ID: 1848499
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use of an immunoradiometric assay and a radioimmunoassay for the detection of free beta-human chorionic gonadotropin.
    Shapiro AI; Wu TF; Ballon SC; Lamb EJ
    Obstet Gynecol; 1985 Apr; 65(4):545-9. PubMed ID: 2580254
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sonographic characteristics of post-molar gestational trophoblastic neoplasia at diagnosis and during follow-up, and relationship with methotrexate resistance.
    Epstein E; Joneborg U
    Ultrasound Obstet Gynecol; 2020 Nov; 56(5):759-765. PubMed ID: 31909527
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Beta-hCG vs intact hCG assays in the detection of trophoblastic disease.
    Rinker AD; Tietz NW
    Clin Chem; 1989 Aug; 35(8):1799-800. PubMed ID: 2474392
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Uterine artery Doppler blood flow in cases of hydatidiform mole and its correlation with beta-hCG.
    Abd El Aal DE; El Senosy ED; Kamel MA; Atwa M
    Eur J Obstet Gynecol Reprod Biol; 2003 Dec; 111(2):129-34. PubMed ID: 14597239
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alpha subunit and human chorionic gonadotropin in normal pregnancy and gestational trophoblastic disease.
    Elegbe RA; Pattillo RA; Hussa RO; Hoffmann RG; Damole IO; Finlayson WE
    Obstet Gynecol; 1984 Mar; 63(3):335-7. PubMed ID: 6199703
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
    Kitajima T; Mochizuki M; Nishimura R
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The hCG assay in the treatment of trophoblastic disease.
    Pattillo RA; Hussa RO
    J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Coexisting epithelioid trophoblastic tumor and placental site trophoblastic tumor of the uterus following a term pregnancy: report of a case and review of literature.
    Zhang X; Zhou C; Yu M; Chen X
    Int J Clin Exp Pathol; 2015; 8(6):7254-9. PubMed ID: 26261623
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization of antigenic components from circulating immune complexes in patients with gestational trophoblastic neoplasia.
    Lahey SJ; Steele G; Rodrick ML; Berkowitz R; Goldstein DP; Ross DS; Ravikumar TS; Wilson RE; Byrn R; Thomas P
    Cancer; 1984 Mar; 53(6):1316-21. PubMed ID: 6198067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.